Results

1–8 of 8 results for Ferhina S Ali

Impact of Initial Monthly Doses of Aflibercept on Visual Outcomes in Eyes With Diabetic Macular Edema in Routine Clinical Practice in the US
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2023
Expert Panel: Faricimab and Aflibercept 8 mg in AMD
John T. Thompson, MD
Andrew A. Moshfeghi, MD, MBA, FASRS
Manjot K Gill, MD, FASRS
Christina Y Weng, MD, MBA, FASRS
Ferhina S Ali, MD, MPH
Ian Pearce, MB ChB BSc FRCOPHTH
Annual Meeting Talks
2024
Treatment Patterns and Visual and Health Function in Neovascular Age-Related Macular Degeneration (nAMD): Medicare Current Beneficiary Survey Analysis
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2021
Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more
Jayanth Sridhar, MD
Daniel L Chao, MD, PhD
Ferhina S Ali, MD, MPH
Member Podcasts
2020
Patient Comfort and Antimicrobial Efficacy of Aqueous Chlorhexidine Versus Povidone Iodine as Disinfectant Prior to Bilateral Intravitreal Injections
Ferhina S Ali, MD, MPH
Updates from the Field
2019
Patient Comfort and Antimicrobial Efficacy of Aqueous Chlorhexidine Versus Povidone Iodine as Disinfectant to Bilateral Intravitreal Injections
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2019
Ferhina Ali Last Word
Ferhina S Ali, MD, MPH
Annual Meeting Talks
Impact of Posterior Vitreous Detachment at Baseline on Treatment Outcomes For Diabetic Macular Edema in the VISTA and VIVID Trials
Ferhina S Ali, MD, MPH
On Demand Cases, Courses, and Papers
2017